AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

CVS GROUP PLC

Transaction in Own Shares Nov 4, 2025

7590_pos_2025-11-04_dab3b5f6-717f-43ac-8888-2c716519385a.html

Transaction in Own Shares

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 9953F

CVS Group plc

04 November 2025

04 November 2025

CVS GROUP plc

("CVS" or the "Company" and, together with its subsidiaries, the "Group")

Transaction in own shares

CVS announces that on 03 November 2025 it purchased the following number of its ordinary shares of 0.2 pence each ("Ordinary Shares") from Joh. Berenberg, Gossler & Co. KG, London Branch ("Berenberg"), in accordance with the terms of the share buyback programme announced on 24 October 2025 (the "Share Buyback Programme").

Date of purchase: 03/11/2025
Aggregate number of Ordinary Shares purchased: 34,670
Lowest price paid per share (GBp): 1,234.00
Highest price paid per share (GBp): 1,262.00
Volume weighted average price paid per share (GBp): 1,245.88

CVS intends to cancel all of the purchased Ordinary Shares.

Following settlement of the above purchases and cancellation of the Ordinary Shares purchased, CVS will have 71,527,894 Ordinary Shares in issue and holds no Ordinary Shares in treasury.

The total number of voting rights in CVS is therefore 71,527,894 and this figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, CVS under the Financial Conduct Authority's Disclosure and Transparency Rules.

Since the commencement of the Share Buyback Programme, the Company has repurchased 212,807 Ordinary Shares in aggregate at a weighted average price of 1,291.56 pence per share.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), as it forms part of Retained EU Law as defined in the European Union (Withdrawal) Act 2018, the table below contains detailed information of the individual trades made by Berenberg as part of the Share Buyback Programme.

Individual transactions:

Number of

Ordinary Shares purchased
Transaction price (GBp share) Time of

transaction (UK Time)
Transaction

reference number
Trading Venue
16 1248 03/11/2025 08:01:29 1326106128943535 XLON
330 1252 03/11/2025 08:05:51 1326106128944195 XLON
102 1248 03/11/2025 08:08:44 1326106128944527 XLON
282 1246 03/11/2025 08:15:09 1326106128945208 XLON
287 1246 03/11/2025 08:15:09 1326106128945209 XLON
227 1246 03/11/2025 08:28:59 1326106128946297 XLON
70 1246 03/11/2025 08:28:59 1326106128946305 XLON
365 1252 03/11/2025 08:45:32 1326106128947668 XLON
70 1252 03/11/2025 08:48:29 1326106128947870 XLON
98 1250 03/11/2025 08:52:49 1326106128948149 XLON
92 1250 03/11/2025 08:52:49 1326106128948150 XLON
15 1246 03/11/2025 08:55:52 1326106128948372 XLON
419 1246 03/11/2025 08:55:52 1326106128948373 XLON
64 1244 03/11/2025 09:07:24 1326106128949167 XLON
159 1242 03/11/2025 09:10:00 1326106128949350 XLON
96 1246 03/11/2025 09:40:32 1326106128951226 XLON
265 1244 03/11/2025 09:41:13 1326106128951288 XLON
317 1244 03/11/2025 10:13:23 1326106128953669 XLON
93 1244 03/11/2025 10:13:23 1326106128953673 XLON
51 1236 03/11/2025 10:29:18 1326106128954843 XLON
40 1236 03/11/2025 10:29:18 1326106128954844 XLON
151 1234 03/11/2025 10:53:28 1326106128956610 XLON
168 1236 03/11/2025 11:30:36 1326106128959105 XLON
1103 1240 03/11/2025 11:49:28 1326106128961349 XLON
1112 1240 03/11/2025 11:49:28 1326106128961353 XLON
116 1240 03/11/2025 11:49:34 1326106128961361 XLON
1128 1238 03/11/2025 12:00:00 1326106128962170 XLON
87 1236 03/11/2025 12:42:16 1326106128964559 XLON
287 1236 03/11/2025 12:55:57 1326106128965438 XLON
169 1236 03/11/2025 12:57:36 1326106128965538 XLON
114 1236 03/11/2025 12:57:36 1326106128965539 XLON
169 1236 03/11/2025 13:00:00 1326106128965695 XLON
12 1236 03/11/2025 13:00:00 1326106128965696 XLON
212 1236 03/11/2025 13:07:32 1326106128966204 XLON
169 1236 03/11/2025 13:07:32 1326106128966205 XLON
169 1236 03/11/2025 13:07:32 1326106128966207 XLON
169 1236 03/11/2025 13:07:32 1326106128966208 XLON
281 1236 03/11/2025 13:07:32 1326106128966209 XLON
169 1236 03/11/2025 13:07:32 1326106128966210 XLON
169 1236 03/11/2025 13:07:32 1326106128966211 XLON
169 1236 03/11/2025 13:10:02 1326106128966462 XLON
22 1236 03/11/2025 13:10:02 1326106128966463 XLON
169 1236 03/11/2025 13:12:18 1326106128966562 XLON
169 1236 03/11/2025 13:12:18 1326106128966563 XLON
169 1236 03/11/2025 13:12:18 1326106128966564 XLON
169 1236 03/11/2025 13:12:18 1326106128966565 XLON
281 1236 03/11/2025 13:12:18 1326106128966566 XLON
169 1236 03/11/2025 13:12:18 1326106128966567 XLON
169 1236 03/11/2025 13:12:18 1326106128966568 XLON
169 1236 03/11/2025 13:12:18 1326106128966569 XLON
169 1236 03/11/2025 13:12:18 1326106128966570 XLON
169 1236 03/11/2025 13:12:19 1326106128966572 XLON
21 1236 03/11/2025 13:12:19 1326106128966573 XLON
169 1236 03/11/2025 13:17:22 1326106128966880 XLON
169 1236 03/11/2025 13:17:22 1326106128966883 XLON
206 1236 03/11/2025 13:17:22 1326106128966884 XLON
169 1236 03/11/2025 13:54:41 1326106128969620 XLON
120 1236 03/11/2025 13:54:41 1326106128969623 XLON
169 1236 03/11/2025 14:04:00 1326106128970402 XLON
169 1236 03/11/2025 14:09:41 1326106128971054 XLON
535 1236 03/11/2025 14:09:41 1326106128971058 XLON
70 1244 03/11/2025 14:13:16 1326106128971384 XLON
1316 1242 03/11/2025 14:14:38 1326106128971534 XLON
397 1240 03/11/2025 14:14:38 1326106128971553 XLON
1146 1240 03/11/2025 14:14:44 1326106128971599 XLON
462 1240 03/11/2025 14:15:02 1326106128971623 XLON
1553 1246 03/11/2025 14:34:02 1326106128974894 XLON
1548 1246 03/11/2025 14:34:02 1326106128974895 XLON
808 1244 03/11/2025 14:34:38 1326106128975005 XLON
178 1244 03/11/2025 14:34:38 1326106128975009 XLON
132 1242 03/11/2025 14:34:57 1326106128975052 XLON
620 1242 03/11/2025 14:35:34 1326106128975233 XLON
1401 1242 03/11/2025 14:35:42 1326106128975303 XLON
1325 1244 03/11/2025 14:38:25 1326106128975813 XLON
192 1244 03/11/2025 14:38:25 1326106128975814 XLON
71 1242 03/11/2025 14:40:58 1326106128976365 XLON
1374 1250 03/11/2025 14:48:32 1326106128978006 XLON
1374 1252 03/11/2025 14:49:06 1326106128978156 XLON
683 1252 03/11/2025 14:49:06 1326106128978158 XLON
1008 1254 03/11/2025 14:50:27 1326106128978450 XLON
1306 1262 03/11/2025 14:54:51 1326106128979223 XLON
837 1262 03/11/2025 14:54:53 1326106128979224 XLON
110 1260 03/11/2025 14:56:54 1326106128979598 XLON
676 1260 03/11/2025 15:00:00 1326106128980187 XLON
84 1260 03/11/2025 15:00:01 1326106128980198 XLON
90 1260 03/11/2025 15:00:59 1326106128980378 XLON
1274 1258 03/11/2025 15:01:18 1326106128980442 XLON
1139 1260 03/11/2025 15:02:30 1326106128980806 XLON
172 1260 03/11/2025 15:02:30 1326106128980808 XLON
192 1260 03/11/2025 16:04:45 1326106128991638 XLON

Contacts

CVS Group plc                                                                                                                                                 via Camarco

Richard Fairman, CEO

Robin Alfonso, CFO

Paul Higgs, Chief Veterinary Officer

Charlotte Page, Head of Investor Relations

Peel Hunt LLP (Nominated Adviser & Joint Broker)                                                                                 +44 (0)20 7418 8900

Christopher Golden / James Steel / Andrew Clark

Berenberg (Joint Broker)                                                                                                                             +44 (0)20 3207 7800

Toby Flaux / Michael Burke / Milo Bonser / Brooke Harris-Lowing

Camarco (Financial PR)                                                                                                                            [email protected]

Ginny Pulbrook                                                                                                                                                +44 (0)7961 315 138

Letaba Rimell

Tilly Butcher

About CVS Group plc (www.cvsukltd.co.uk)

CVS Group is an AIM-listed provider of veterinary services with operations in the UK and Australia.  CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

The Group now operates c.470 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business ("Animed Direct").

The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

POSUPGMGGUPAGMW

Talk to a Data Expert

Have a question? We'll get back to you promptly.